Feeling grateful to participant #60 & team @ Eastern Health for taking part in our #OXTOX #RCT - helping us see if #Ibudilast prevents/reduces #CIPN in people with #CRCSM treated with oxaliplatin #Chemo almost 2/3rd to target recruitment #SuppOnc #PsyOnc #MedOnc #bowelcancer

Thank you 🙏🏽 #OXTOX #RCT participant #59 from #ConcordCancerCentre - wonderful to have you on board to help find out if #ibudilast prevents #CIPN from #oxaliplatin in #CRCSM @GICancer @drprunellab @MartinStockler @janette_vardy #SuppOnc #SurvOnc #OzOnc

& today we welcome another participant (#58) from Mid-North Coast Cancer Centre to #OXTOX #RCT - thanks 🙏🏽to them & #clinicaltrials team! Racing towards our 100 participant target #SuppOnc #PsyOnc #OzOnc #CRCSM @GICancer @janette_vardy @COSAoncology

Feeling grateful to 2 new participants on #OXTOX #RCT & to teams @ Sydney Aventist & Royal North Shore Hospitals. Now 57/100 people on study assessing whether ibudilast reduces #CIPN during #oxaliplatin #chemo for #CRCSM #SuppOnc #OzOnc @GICancer

Welcoming, with thanks, participant #55 in the #OXTOX #ClinicalTrial with team at Eastern Health in Vic helping us understand if #ibudilast prevents or reduces #CIPN in people #CRCSM on #oxaliplatin @GICancer @POCOG1 @Sydney_Science @syd_health #OzOnc

Congrats to the #OxTOx team on flying past the recruitment halfway mark! Thank you to all the incredible patients joining this important study. Learn more about OxTOx: gicancer.org.au/genesis-of-a-c…

💉💉💉A/Prof. Haryana Dhillon💉💉💉 @hagsie

3 months ago

Congrats to the #OxTOx team on flying past the recruitment halfway mark! Thank you to all the incredible patients joining this important study. Learn more about OxTOx: gicancer.org.au/genesis-of-a-c…

0 2 11 938 0

Download Gif

3 people in 1 day, #OxTOx #RCT has 53 participants. Thank you to 2 new people from Central Coast Cancer Centre & 1 from RNSH - & of course to #ClinicalTrial teams at both sites. #SuppOnc #OzOnc @GICancer @janette_vardy @COSAoncology @UTS_CST @POCOG1

& on 1st Feb, colleagues @ Central Coast Cancer Centre randomised participant 51 to #OxTox. Grateful to participant helping us learn about interventions for #CIPN #CRCSM @GICancer @janette_vardy @SuppOnc #OzOnc

So many thanks to team @ Eastern Health who recruited 50th participant to #OXTOX trial today. This generous person takes us halfway to our recruitment goal of 100 to understand impact of ibudilast on #CIPN in #CRCSM #SuppOnc @GICancer @COSAoncology @MOGA_ORG @UTS_CST @UTS_CST

2 people randomised to #OXTOX #RCT in 2024 so far! Grateful to participants & teams @ Eastern Health Vic & Illawarra Cancer Centre for their dedication & support. Almost 1/2 way to our recruitment target to see we can reduce #CIPN in oxaliplatin treated #CRC @GICancer #SuppOnc

Final day before @Sydney_Uni summer shutdown #OXTOX participant #47 is randomised! Grateful for their generous participation & the team @ #SAN. Every person takes us closer to know if #Ibudilast can prevent or reduce neurotoxicity from #Oxaliplatin in people with #CRCSM @GICancer

Our thanks to #OXTOX participant #46, @ErinMoth1 & team @ Macquarie Uni Hospital for joining this #RCT & helping us find ways to reduce or prevent #CIPN in people #CRCSM receiving #Oxaliplatin #SuppOnc @GICancer @COSAoncology @janette_vardy @MartinStockler @Sydney_Uni

& today we thank the 45th #OXTOX participant (3rd to join this week), along with team at the SAN hospital in Sydney for supporting #RCT to prevent #CIPN in #CRCSM #SuppOnc #PsyOnc @GICancer @janette_vardy @TrialsCentre @Sydney_Uni

& this pm thanking participant #44 on #OXTOX #RCT along with team #CentralCoastCancerCentre #Gosford - getting us almost to halfway to our recruitment target #CIPN #SuppOnc #PSyOnc @GICancer @DrAlexFlynn @janette_vardy

We’re now going to discuss #AGITG23 advanced @GICancer trials- 1st is #OXTOX led by A/Prof Haryana Dhillon. OXTOX is currently recruiting (and has changed eligibility criteria recently!) - you can find out more about how this trial could improve #QoL at asm.gicancer.org.au/agitg-abstract…

keyboard_arrow_left Previous keyboard_arrow_right Next

Grateful to participant #41 & team @CeraCRGH for randomising to #OXTOX study this morning. 41/100 people taking part in study to prevent #CIPN in people with #CRCSM #bowelcancer receiving oxaliplatin #SuppOnc #OzOnc @janette_vardy @drprunellab @MartinStockler

Amazing to have 3 people with #CRCSM #bowelcancer join the #OXTOX #RCT for #CIPN this week! 40 people now taking part, thanks to Nepean team recruiting 2 people & Illawarra team for recruiting the 3rd. @GICancer @DKarikios @janette_vardy @drcbsteer @DrChristinaTeng @drprunellab

@DrChristinaTeng @GICancer @janette_vardy @DKarikios @ErinMoth1 @drprunellab @MartinStockler 22/37 participants have been recruited to #OxTox from our regional & rural collaborating centres. You are so right @DrChristinaTeng, Regional NSW does 🫶 #ClinicalTrials!

we've now recruited 37/100 participants into #OxTox #RCT #CIPN #CRCSM @GICancer @janette_vardy @DKarikios @ErinMoth1 @drprunellab @MartinStockler

Incredible to have generous 3 new participants in our #OxTox #RCT (2/3 from regional centres), 🙏 to them & #ClinicalTeams @ Concord, Orange, & Border Cancer Centres #CIPN #CRCSM @GICancer @drprunellab @drcbsteer @CraigUnderhill @CancerAustralia @cancerNSW